Inogen's ROE % for the quarter that ended in Dec. 2023 was -48.79%. Inogen's PB Ratio for the quarter that ended in Dec. 2023 was 0.61.
Inogen's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -79.98%.
Inogen ROE % Adjusted to Book Value Historical Data
The historical data trend for Inogen's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Inogen's ROE % Adjusted to Book Value
For the Medical Devices subindustry, Inogen's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inogen's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inogen's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Inogen's ROE % Adjusted to Book Value falls into.
Inogen ROE % Adjusted to Book Value Calculation
Inogen's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inogen ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Inogen's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INGN has been successfully added to your 